Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Controlled Release

18 Mar 2013 - 19 Mar 2013 - London, UK



Bookmark and Share


SMi presents its 10th annual conference on . . .

Controlled Release – the only conference in Europe to focus specifically on controlled release.

At this well-established annual event you will hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months.  

ATTEND TO:

• Discover the very latest developments in this innovative and booming industry

• New for 2013:

- Investigating structure-activity relationships of siRNA nanoparticles

- Challenges of pre-clinical gastro-retentive dosage form development

- Numerous case studies from big pharma laboratories – such as GSKs formulation development programme

• Benefit from an interactive half-day post-conference workshop on SMART formulation design: tools and strategies for complex formulation design and problem solving

KEY SPEAKERS INCLUDE:

Michael Keller, PDU Parenteral, Topical & siRNA Lead, Novartis

Andy Lewis, Director, Ipsen

Petra Wicklandt, CMC Development, Merck

Howard Stevens, Professor, Exploratory Drug Discovery, University of Strathclyde

David Elder, Externalisation Director, GlaxoSmithKline

Monica Rosa, Director, SigmoidPharma

Navnit Shah, Distinguished Scientist, Roche

Mark Wilson, Director, Collaboration Management, GlaxoSmithKline

Dmitry Samarsky, Technology & Business Development, Ribobio

Richard Elkes, Senior Research Scientist, Merck 

and many more . . .

Click here for the programme, full speaker line-up and to register http://www.smi-online.co.uk/goto/controlledrelease27.asp 



Further information
Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!